NIRMAN2024-10-012025-03-31NIRMAN2025-03-31NIRMAN2024-03-31NIRMAN2024-04-012025-03-31NIRMAN2024-10-012025-03-31in-capmkt:OtherExpenses1MemberNIRMAN2024-04-012025-03-31in-capmkt:OtherExpenses1MemberNIRMAN2024-10-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares000000NIRMANNOTLISTEDINE0OK701014NIRMAN AGRI GENETICS LIMITEDSMEEquity2024-04-012025-03-312025-05-302025-05-27INRLakhsHalf YearlyYearlySingle segmentBusiness of production, processing and marketing of high-quality hybrid seeds, Pesticides, Bio-organic for different crops like corn, sunflower, cotton, paddy, grain sorghum etc.2025-05-3017:00:002025-05-3018:30:00trueCash Flow IndirectDeclaration of unmodified opinionfalsefalseNANAfalsetrue2025-03-31https://nirmanagrigen.com/falsefalseNot Applicable2024-10-012025-03-31AuditedStandalone124071800001240718000106768700000918600010400050880001857400011006390001400790000140079000014007900032020003760003578000136501000000136501000136501000800970001017.0417.041. The above statement of financial results as approved by the Audit Committee have been approved by the Board of Directors at its meeting held on 30th May ,2025. <BR> 2. The statutory auditors have carried out review of the audited results of the company for quarter ended & year ended 31/03/2025 <BR> 3. The company has single reportable business segment. Hence, no separate information for segment wise disclosure is given in accordane with the requirements of Accounting Standard(AS)-17 - "Segment Reporting". <BR> 4. The above Audited Standalone financial results are in compliance with Accounting Standards (AS) as prescribed under Section 133 of Companies Act, 2013. <BR> 5. As per MCA Notification dated 16th February, 2015, Companies whose shares are listed as SME exchange as referred in Chapter XB of SEBI(Issue of Capital and Disclosure Requirements) Regulations,2009, are exempted from the compulsory requirement of adoption of IND-AS. <BR> 6. The company is not having any subsidiary, associate or joint venture, therefore, it has prepared only standalone results. <BR> 7. Earing Per Share - EPS is calculated on the weighted average of the share capital received by the company. Half yearly EPS is not annualised. <BR> 8. Figures of quarter 31/03/2025 represent the difference between the audited figures in respect of full financial years and unpublished unaudited figures of three months ended 31/12/2024. <BR> 9. The company is listed as SME exchange w.e.f. 28th March, 2023 <BR> 10. Statement of Assets and Liabilities as at 31st March, 2025 and as on 31st March, 2024 is enclosed herewith. <BR> 11. The Statutory Auditors have issued unmodified opinion on the financial statements of the Company for the quarter and year ended 31st March, 2025. <BR> 12. The figures for the previous year have been recast/restated wherever is necessary to confirm with the current period's classification2024-04-012025-03-31AuditedStandalone23651760001844000236702000020516720000017764000219000638200030239000210627600026074400002607440000260744000750800037600078840002528600000002528600002528600008009700010101931800031.5731.57Other expenses18574000Other expenses3023900080097000101931800001099415000000000004387000033660003366000023600000313530001130768000216870000000021687000175000-67600001032890001757000126232000037048100037501500025871700000323000100453600011307680002190006382000000000006601000-287709000-2591350001440000-49933000014312000-581025000-574424000-31368000000000-31368000000-3136800000000000002413500000-117899000000000-129000093635000009363500020489000000185000016019000220000046080900046320900000463209000243164000024316400015553000258717000AuditedtrueCA Devendra C. Belantrue2026-05-31